2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$68.72-$0.20 (-0.30%)
Price as of Jun 23, 2026 7:09 PM EDT- $13.5BMarket Cap
- 63.41%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$68.72-$0.20 (-0.30%)
BBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $68.92 | ||
Change | +$2.65 (+4.00%) | ||
Open | $66.35 | ||
High | $69.66 | ||
Low | $66.30 | ||
Previous Close | $66.27 | ||
Volume | 2,539,872 | ||
30-Day Average Volume | 2,862,505 | ||
1-Week Change | 1.35% | ||
1-Month Change | -0.29% | ||
1-Year Change | 63.41% | ||
3-Year Change | 327.01% | ||
5-Year Change | 14.22% | ||
Fundamentals | |||
Shares Outstanding | 195.9M | ||
Total Assets | $1.4B | ||
Market Cap | $13.5B | ||
Enterprise Value | $13.8B | ||
Period: QTR TTM FY | |||
Revenue | $180.6M | ||
Net Income | -$166.6M | ||
Free Cash Flow | -$197.3M | ||
EBIT | -$165.3M | ||
EBITDA | -$164.1M | ||
Net Working Capital | $424.9M | ||
EPS | -$0.84 | ||
Enterprise Value/EBITDA | -84 | ||
Enterprise Value/Revenue | 76 | ||
P/B | -6 | ||
P/E | -82 | ||
PEG | -5 | ||
Price/Free Cash Flow | -68 | ||
Price/Operating Cash Flow | -68 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue